WO2000022163A3 - Verfahren und kit zum direkten nachweis von nukleotidsequenzen, aminosäuresequenzen oder antigenen - Google Patents

Verfahren und kit zum direkten nachweis von nukleotidsequenzen, aminosäuresequenzen oder antigenen Download PDF

Info

Publication number
WO2000022163A3
WO2000022163A3 PCT/EP1999/007709 EP9907709W WO0022163A3 WO 2000022163 A3 WO2000022163 A3 WO 2000022163A3 EP 9907709 W EP9907709 W EP 9907709W WO 0022163 A3 WO0022163 A3 WO 0022163A3
Authority
WO
WIPO (PCT)
Prior art keywords
kit
amino acid
antigens
directly detecting
acid sequences
Prior art date
Application number
PCT/EP1999/007709
Other languages
English (en)
French (fr)
Other versions
WO2000022163A2 (de
Inventor
Werner Lehmann
Original Assignee
Attomol Gmbh Molekulare Diagno
Werner Lehmann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Attomol Gmbh Molekulare Diagno, Werner Lehmann filed Critical Attomol Gmbh Molekulare Diagno
Priority to AU64713/99A priority Critical patent/AU6471399A/en
Priority to EP99952563A priority patent/EP1121469A2/de
Publication of WO2000022163A2 publication Critical patent/WO2000022163A2/de
Publication of WO2000022163A3 publication Critical patent/WO2000022163A3/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804Nucleic acid analysis using immunogens
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6853Nucleic acid amplification reactions using modified primers or templates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Die Erfindung betrifft ein als Restrictase Chain Reaction (RCR) bezeichnetes Verfahren zum direkten Nachweis von Target-Nukleotid- oder Target-Aminosäuresequenzen oder von Target-Antigenen durch Amplifikation einer Nukleotidsequenz mittels einer DNS-Polymerase, eines Restriktionsenzyms und einer Matrix-DNS, an der durch Bindung eines initialen Primers dieser Primer amplifiziert wird. Desweiteren betrifft die Erfindung einen diese Matrix-DNS beinhaltenden Kit und die Verwendung dieses Kits in der medizinischen Diagnostik und kriminalistischen Spurenanalytik sowie für Umwelt-, Lebens- und Arzneimittelanalysen.
PCT/EP1999/007709 1998-10-12 1999-10-11 Verfahren und kit zum direkten nachweis von nukleotidsequenzen, aminosäuresequenzen oder antigenen WO2000022163A2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU64713/99A AU6471399A (en) 1998-10-12 1999-10-11 Method and kit for directly detecting nucleotide sequences, amino acid sequencesor antigens
EP99952563A EP1121469A2 (de) 1998-10-12 1999-10-11 Verfahren und kit zum direkten nachweis von nukleotidsequenzen, aminosäuresequenzen oder antigenen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19848297.3 1998-10-12
DE19848297 1998-10-12

Publications (2)

Publication Number Publication Date
WO2000022163A2 WO2000022163A2 (de) 2000-04-20
WO2000022163A3 true WO2000022163A3 (de) 2000-08-03

Family

ID=7885036

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1999/007709 WO2000022163A2 (de) 1998-10-12 1999-10-11 Verfahren und kit zum direkten nachweis von nukleotidsequenzen, aminosäuresequenzen oder antigenen

Country Status (3)

Country Link
EP (1) EP1121469A2 (de)
AU (1) AU6471399A (de)
WO (1) WO2000022163A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10164219A1 (de) * 2001-12-31 2003-07-17 Reinald Repp Verfahren zur Detektion von Nukleinsäuren unter Verwendung festphasengebundener Primer und Abspaltung der Produkte einer zyklischen Amplifikationsreaktion (Trap Release Primer Amplification (TRAmp)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990006045A2 (en) * 1988-11-21 1990-06-14 Dynal As Nucleic acid probes
EP0408918A1 (de) * 1989-06-23 1991-01-23 Canon Kabushiki Kaisha Verfahren zum Nachweis von Nucleinsäuren
WO1992001813A1 (en) * 1990-07-25 1992-02-06 Syngene, Inc. Circular extension for generating multiple nucleic acid complements
US5405746A (en) * 1988-03-23 1995-04-11 Cemu Bioteknik Ab Method of sequencing DNA

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5405746A (en) * 1988-03-23 1995-04-11 Cemu Bioteknik Ab Method of sequencing DNA
WO1990006045A2 (en) * 1988-11-21 1990-06-14 Dynal As Nucleic acid probes
EP0408918A1 (de) * 1989-06-23 1991-01-23 Canon Kabushiki Kaisha Verfahren zum Nachweis von Nucleinsäuren
WO1992001813A1 (en) * 1990-07-25 1992-02-06 Syngene, Inc. Circular extension for generating multiple nucleic acid complements

Also Published As

Publication number Publication date
AU6471399A (en) 2000-05-01
WO2000022163A2 (de) 2000-04-20
EP1121469A2 (de) 2001-08-08

Similar Documents

Publication Publication Date Title
FI98932C (fi) Menetelmä monistetun DNA-näytteen aiheuttaman kontaminaation pienentämiseksi amplifikaatiomenetelmässä
CA2884246C (en) Multiplex pyrosequencing using non-interfering noise-canceling polynucleotide identification tags
WO1999005315A3 (en) Nucleic acid sequence analysis
WO2005028629A3 (en) Whole genome expression analysis system
WO1996006190A3 (en) Coupled amplification and ligation method
DE69029726T2 (de) Festphasendiagnose von medizinischen konditionen
AU2001284295A1 (en) Method of sequencing dna
WO2003054209A3 (en) A method of reducing non-specific amplification in pcr
WO2002072773A3 (en) Methods and compositions for amplification of rna sequences
EP0776981A3 (de) Oligonukleotid-Primer für Amplifizierung von HCV-Nukleinsäure
CA2189941A1 (en) Fluorescence Polarization Detection of Nucleic Acids
YU48903A (sh) Sistem probe sa potapajućom test trakom i postupak sa probom za detekciju i/ili određivanje specifičnih sekvenci nukleinske kiseline
CA2295942A1 (en) Enhancement of the specificity of nucleic acid amplification by carrier nucleic acid
WO1998011259A3 (en) Composition, method and kit for detection and identification of sexually transmitted disease microorganisms
WO1996015264A3 (en) Method for identifying nucleic acid sequences from different biological sources through amplification of the same
WO1996021042A3 (en) Primers for the pcr amplification of metastatic sequences
WO1996015264B1 (en) Method for identifying nucleic acid sequences from different biological sources through amplification of the same
EP1251182A3 (de) Verfahren zur Amplifikation und Erkennung von Nukleinsäure-Zielsequenzen unter Verwendung von thermostabilen Enzymen
WO2004013305A3 (en) Improved compositions for in vitro amplification of nucleic acids
WO2000022163A3 (de) Verfahren und kit zum direkten nachweis von nukleotidsequenzen, aminosäuresequenzen oder antigenen
WO2004050857A3 (en) Splice variant of human sodium iii channel (hnaiii18)
AU6390690A (en) Nucleic acid probes and methods for detecting cryptococcus neoformans
WO2002072881A3 (en) Method for the amplification and detection of hbv dna using a transcription based amplification
BR0014017A (pt) Método para detectar alterações em um gene através de pcr de ampla abrangência usando elementos humanos móveis
WO2001081621A3 (de) Verfahren, diagnose-kit und mikroarray zur bestimmung des rhesus-faktors

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref country code: AU

Ref document number: 1999 64713

Kind code of ref document: A

Format of ref document f/p: F

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 1999952563

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999952563

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1999952563

Country of ref document: EP